International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 6

Human-in-the-Loop Computational Phytopharmacology: Expert Curation, Model Oversight, Mechanistic Reasoning, and Translational Decision Confidence
Download PDF


, ,
  1. Department of Artificial Intelligence for Polyketide and Alkaloid Discovery, School of Pharmacy, University of California, San Francisco, San Francisco, United States.
  2. Department of Machine Learning for Biosynthetic Gene Clusters, Graduate School of Pharmacy, University of Tokyo, Tokyo, Japan.
Citation
Vancouver
Chen L, Sato Y, Harris O. Human-in-the-Loop Computational Phytopharmacology: Expert Curation, Model Oversight, Mechanistic Reasoning, and Translational Decision Confidence. Int J Pharm Phytopharmacol Res. 2025;15(6):1-10. https://doi.org/10.51847/QfrhT9l78x
APA
Chen, L., Sato, Y., & Harris, O. (2025). Human-in-the-Loop Computational Phytopharmacology: Expert Curation, Model Oversight, Mechanistic Reasoning, and Translational Decision Confidence. International Journal of Pharmaceutical And Phytopharmacological Research, 15(6), 1-10. https://doi.org/10.51847/QfrhT9l78x
Download citation:   EndNote   RIS
Article Link:
Downloads: 21
Views: 66
Abstract

Computational phytopharmacology increasingly uses artificial intelligence, natural product informatics, target prediction, pathway analysis, safety modeling, and evidence integration to support discovery-stage decisions. However, phytopharmacological data are often chemically complex, biologically heterogeneous, and dependent on uncertain botanical identity, chemical annotation, assay context, target evidence, pathway inference, and safety interpretation. This article proposes an original human-in-the-loop framework for computational phytopharmacology in which expert curation, model oversight, mechanistic reasoning, uncertainty interpretation, translational review, and decision-confidence assessment are embedded across the discovery workflow. The framework distinguishes expert curation from data annotation, model oversight from model selection, explainability review from causal interpretation, decision confidence from clinical readiness, and translational review from regulatory endorsement. It positions human expertise before, during, and after computational inference through checkpoints for botanical identity, chemical annotation, bioactivity evidence, assay relevance, training-data suitability, model-output interpretation, uncertainty communication, bias detection, biological plausibility, exposure plausibility, safety review, herb–drug interaction review, evidence grading, validation planning, and decision-boundary control. The main contribution is a structured framework that treats computational outputs as research-prioritisation evidence requiring transparent documentation, expert disagreement recording, validation planning, audit trails, and feedback loops for data and model refinement. The framework is conceptual and does not represent an implemented, clinically validated, or regulatory-approved decision-support system.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 1
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.